Literature DB >> 16781882

Ral: mediator of membrane trafficking.

Ellen M van Dam1, Phillip J Robinson.   

Abstract

Ral is a multifunctional small GTPase involved in tumorigenesis and in controlling intracellular membrane trafficking. It is mainly activated by factors downstream of Ras, or independently of these factors and operates by protein-protein interactions with an expanding repertoire of partners. RalA is a positive regulator of calcium-evoked exocytosis via binding phospholipase D and is involved in G protein coupled receptor signalling by binding phospholipase C-delta1. The binding of Ral to calmodulin links to intracellular trafficking events. Another link is direct binding of activated Ral (Ral-GTP) to the endocytic and exocytic machineries. Ral-GTP binds RalBP1, which connects to receptor-mediated endocytosis via AP-2. Alternatively, Ral-GTP binds the exocyst complex, which controls secretory vesicle trafficking in regulated secretion and filopodia formation. Thus, Ral-GTP "chooses" between different membrane trafficking pathways. Other Ral partners are still being uncovered that may provide further mechanistic insights into how Ral controls diverse membrane trafficking pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781882     DOI: 10.1016/j.biocel.2006.04.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  31 in total

1.  Ral inhibits ligand-independent Notch signaling in Drosophila.

Authors:  Bomsoo Cho; Janice A Fischer
Journal:  Small GTPases       Date:  2012-07-01

2.  Ral GTPase and the exocyst regulate autophagy in a tissue-specific manner.

Authors:  Kirsten Tracy; Panagiotis D Velentzas; Eric H Baehrecke
Journal:  EMBO Rep       Date:  2015-11-23       Impact factor: 8.807

3.  M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex.

Authors:  Koji Hase; Shunsuke Kimura; Hiroyuki Takatsu; Masumi Ohmae; Sayaka Kawano; Hiroshi Kitamura; Masatoshi Ito; Hiroshi Watarai; C Clayton Hazelett; Charles Yeaman; Hiroshi Ohno
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

4.  Ral GTPase promotes asymmetric Notch activation in the Drosophila eye in response to Frizzled/PCP signaling by repressing ligand-independent receptor activation.

Authors:  Bomsoo Cho; Janice A Fischer
Journal:  Development       Date:  2011-02-24       Impact factor: 6.868

5.  Negative regulation of the RalGAP complex by 14-3-3.

Authors:  Dara Leto; Maeran Uhm; Anja Williams; Xiao-wei Chen; Alan R Saltiel
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

6.  GEF-H1: orchestrating the interplay between cytoskeleton and vesicle trafficking.

Authors:  Ritu Pathak; Celine Dermardirossian
Journal:  Small GTPases       Date:  2013-05-06

7.  Rit mutants confirm role of MEK/ERK signaling in neuronal differentiation and reveal novel Par6 interaction.

Authors:  Jennifer L Rudolph; Geng-Xian Shi; Eda Erdogan; Alan P Fields; Douglas A Andres
Journal:  Biochim Biophys Acta       Date:  2007-10-09

8.  Large-scale quantitative LC-MS/MS analysis of detergent-resistant membrane proteins from rat renal collecting duct.

Authors:  Ming-Jiun Yu; Trairak Pisitkun; Guanghui Wang; Juan F Aranda; Patricia A Gonzales; Dmitry Tchapyjnikov; Rong-Fong Shen; Miguel A Alonso; Mark A Knepper
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-02       Impact factor: 4.249

9.  The GTPase RalA regulates different steps of the secretory process in pancreatic beta-cells.

Authors:  Sanda Ljubicic; Paola Bezzi; Nicolas Vitale; Romano Regazzi
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

10.  Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD.

Authors:  Kihoon Han; Myoung-Hwan Kim; Daniel Seeburg; Jinsoo Seo; Chiara Verpelli; Seungnam Han; Hye Sun Chung; Jaewon Ko; Hyun Woo Lee; Karam Kim; Won Do Heo; Tobias Meyer; Hyun Kim; Carlo Sala; Se-Young Choi; Morgan Sheng; Eunjoon Kim
Journal:  PLoS Biol       Date:  2009-09-08       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.